Table 3 TD associated outcomes (‘90 – ‘15)
Outcome | All years | 1990–2005 | 2006–2015 | ||||||
|---|---|---|---|---|---|---|---|---|---|
Median | IQR | Min, Max | Median | IQR | Min, Max | Median | IQR | Min, Max | |
Pre-treatment symptoms, days | 1.4 | 1.1, 2.0 | 0.3, 4.0 | 1.4 | 1.1, 1.7 | 0.3, 4.1 | 2.0 | 1.0, 3.0 | 1.0, 3.3 |
Post-treatment symptoms, days | 1.5 | 1.1, 1.9 | 0.6, 2.2 | 1.4 | 0.8, 1.8 | 0.6, 2.2 | 1.8 | – | 1.5, 2.0 |
- TLUS (abx + loperamide), hrs | 9.6 | 8.2, 11.5 | 8.2, 11.5 | 11.5 | – | – | 8.9 | – | 8.2, 9.6 |
- TLUS (abx – loperamide), hrs | 21.8 | 11.0, 43.2 | 11.0, 43.2 | 16.4 | – | 11.0, 21.8 | 43.2 | – | – |
Prob. Receiving Abx, %* | 57.0 | 19.0, 91.0 | 3.0, 100.0 | 79.0 | – | – | 44.0 | 15.0, 96.0 | 3.0, 100.0 |
Prob. Receiving loperamide, %* | 85.0 | 27.0, 88.0 | 17.0, 90.0 | – | – | – | 85.0 | 27.0, 88.0 | 17.0, 90.0 |
Prob. Receiving IV fluids, %* | 15.0 | 6.0, 19.0 | 0.0, 33.0 | 12.0 | 0.0, 15.0 | 0.0, 15.0 | 17.0 | 6.0, 23.0 | 5.0, 33.0 |
Prob. SIQ or incapacitation, %* | 21.0 | 13.0, 34.0 | 3.0, 55.0 | 16.0 | 5.0, 46.0 | 3.0, 55.0 | 23.0 | 13.0, 34.0 | 4.0, 39.0 |
Prob. Hospital admission, % | 3.0 | 1.0, 13.0 | 0.0, 17.0 | 11.0 | – | 10.0, 13.0 | 2.0 | 1.0, 10.0 | 0.0, 17.0 |
Symptom duration in those not seeking treatment, days | 3.0 | 2.4.0, 3.5.0 | 1.0, 4.3.0 | 3.0.0 | 2.5, 3.8 | 2.1, 4.3 | 2.9 | 1.8, 3.6 | 1.0, 3.8 |